Skip to main content
. 2021 Mar 4;12(1):27–40. doi: 10.1007/s13167-021-00237-2

Fig. 2.

Fig. 2

Molecular mechanisms and factors associated with mitochondrial impairments in neurodegenerative and cardiovascular diseases, and cancer. ADAM10, a disintegrin and 71 metalloprotease 10; APP, amyloid precursor protein; PSEN1, presenilin 1; PSEN2, presenilin 2; EMT, epithelial-mesenchymal transition; mtROS, mitochondrial reactive oxygen species; CVD, cardiovascular disease; DNA, deoxyribonucleic acid; ApoE, apolipoprotein E; SOD2, superoxide dismutase 2; ETC, electron transport chain; DJ1, parkin-associated protein involved with oxidative stress; HTRA2, serine peptidase 2; PD, Parkinson’s disease; mPTP, mitochondrial permeability transition pore; ATP, adenosine triphosphate; PINK1, putative serine threonine kinase; CytC, cytochrome c; ANT, adenine nucleotide translocator; CyPD, cyclophilin D; NDUFS1, anti-oxidative enzyme superoxide dismutase 2 and complex I subunit; VDAC, voltage-dependent anion channel; Parkin, E3 ubiquitin ligase; α-syn, α-synuclein; UCH-L1, ubiquitin carboxy-terminal hydrolase L1; SH3GL2, SH3 domain containing GRB2 like 2/endophilin A1